Safety and Immunovirologic Outcomes with Maraviroc Combination Regimens in Patients with a History of Past Treatment Failures and Virologic Resistance in Brazil: An Open-Label, Multicenter Phase 3b StudyJuvêncio José Duailibe Furtado, Lourenia M. Cassoli, José Valdez Madruga et al.|AIDS Research and Human Retroviruses|2013Cited by 5
Long-Term Efficacy and Complete Scalp Hair Regrowth in Patients With Alopecia Areata Receiving Ritlecitinib 50 mg QD Up to 3 Years in the ALLEGRO Clinical Trial ProgramBrett King, Alexandre Lejeune, Bianca Maria Piraccini et al.|SKIN The Journal of Cutaneous Medicine|2025Cited by 0